Objective: The objective of this study was to assess the association between increased central venous-to-arterial carbon dioxide difference (ΔPCO 2 ) following cardiac surgery with cardiopulmonary bypass and postoperative morbidity and mortality. Design: A prospective, observational, non-interventional study. Patients: Three hundred ninety-three patients undergoing cardiac surgery with cardiopulmonary bypass. Interventions: The primary endpoint was the occurrence of one or more major postoperative complications. A ΔPCO 2 Z 6 mmHg was considered to be abnormal. Data were first analyzed globally, and then according to 4 subgroups based on time course of ΔPCO 2 during the study period: [(1) persistently normal ΔPCO 2 ; (2) increasing ΔPCO 2 ; (3) decreasing ΔPCO 2 ; and (4) persistently high ΔPCO 2 ]. Results: A total of 238 of the 393 (61%) patients developed complications. The major postoperative complication rate did not differ among the 4 groups: 64% (n ¼ 9) in group 1, 62% (n ¼ 21) in group 2, 53% (n ¼ 32) in group 3, and 62% (n ¼ 176) in group 4 (p ¼ 0.568). Mortality rates did not differ among the 4 groups (p 4 0.05). ΔPCO 2 was correlated weakly with perfusion parameters. Conclusions: These results suggested that ΔPCO 2 is not predictive of postoperative complications or mortality.
OVER RECENT YEARS, early goal-directed hemodynamic optimization has been demonstrated to improve postoperative morbidity and mortality. 1, 2 This approach is based on optimization of cardiac output (CO) and/or perfusion parameters, such as central venous saturation (ScvO 2 ) and arterial lactate.
1,2 ScvO 2 is assumed to reflect the matching between arterial oxygen delivery (DO 2 ) and O 2 consumption (VO 2 ). 3, 4 Nevertheless, ScvO 2 is often normal at the time of admission of a patient to the intensive care unit (ICU) despite the presence of persistent signs of hypoxia. 4 Cardiac surgery with cardiopulmonary bypass (CPB) induces ischemiareperfusion syndrome, with a systemic inflammatory response associated with microcirculation and cellular oxygen dysfunctions. 5, 6 These alterations may account for impaired oxygen utilization. Two studies have demonstrated an unfavorable postoperative course in patients with high ScvO 2 despite hemodynamic stabilization. 4, 7 In this context, ScvO 2 measurement could be refined by measuring the central venous-toarterial carbon dioxide partial pressure difference (ΔPCO 2 ). High ΔPCO 2 has been demonstrated to reflect abnormal microcirculation due to mismatching of CO to overall metabolic conditions. 8 ΔPCO 2 correlates with CO and arterial lactate values in septic patients and in patients who have undergone abdominal surgery. 9, 10 High ΔPCO 2 values are associated with complications and death in postoperative patients. 8, 10 Following cardiac surgery, studies have focused mostly on the correlation between ΔPCO 2 , laboratory markers of tissue perfusion (arterial lactate, ScvO 2 ), and CO. [11] [12] [13] No studies had specifically evaluated the association between ΔPCO 2 and postoperative complications in cardiac surgical patients. The authors hypothetized that patients with high ΔPCO 2 had more complications than patients with normal ΔPCO 2 .
The main objective of this study was to investigate the association between ΔPCO 2 and complications in patients following cardiac surgery with CPB. The authors also describe the time-course of ΔPCO 2 in these patients, and assess association between ΔPCO 2 and perfusion variables.
Materials and Methods

Ethics
The study's objectives and procedures were approved by the local independent ethics committee, the Comité de Protection des Personnes. The present manuscript was drafted in compliance with the Strengthening the Reporting of Observational Studies in Epidemiology checklist for cohort studies. 14 
Patients
A prospective, observational study over a 16-month period (2010-2011) was conducted in Amiens University Hospital's surgical ICU. Patients over the age of 18, who had undergone cardiac surgery with CPB, were consecutively included. Patients with incomplete data or who had undergone offpump surgery were excluded.
Some of the patients were included previously in a study that evaluated right ventricular dysfunction in cardiac surgical setting. 15 Anesthesia and CPB management were standardized for all patients. CPB with a heart-lung machine (Stockert Sorin S5 Heart Lung, Milan, Italy) was performed at a target blood flow of 2.4 L/min/m 2 , and mean arterial blood pressure was maintained at more than 60 mmHg first by increasing pump flow or, if blood pressure did not improve, by bolus administration of phenylephrine or norepinephrine. In the ICU, CO was monitored by transthoracic echocardiography and/or continuous CO monitoring using transpulmonary dilution. Circulatory support was guided by institutional protocols to achieve predefined endpoints: mean arterial blood pressure greater than 70 mmHg, cardiac index greater than 2.2 L/min/ m 2 , urine output greater than 0.5 mL/kg/h, ScVO 2 4 70%, and arterial lactates o 2 mmol/L. 
Definitions
Complications were evaluated prospectively during the hospital stay. Complications were defined by 2 senior physicians specializing in cardiac surgery patients (E.L, H.D.), at least one of whom was a cardiologist, for the diagnosis of cardiac complications. In case of disagreement, a third senior physician was consulted. Complications were defined according to international postoperative guidelines, 16 and comprised cardiac complications, reoperation, renal complications (kidney failure defined according to Kidney Disease Improving Global Outcomes guidelines), gastrointestinal complications (mesenteric ischemia defined by computed tomography scanning and/or surgery), and death. 16 Cardiac complications comprise left heart failure (left ventricular ejection fraction below 40%), right heart failure (more than 2 echocardiographic variables of right ventricular dysfunction), need for circulatory support (extracorporeal life support), vasoplegic syndrome (persistent arterial hypotension despite cardiac index over 2.2 L/min/m 2 , adequate fluid rescusitation and treated with more than 4 hours of vasopressor), tamponade, cardiogenic shock, atrial fibrillation (more than 2 h), atrial flutter, ventricular fibrillation, and cardiac arrest.
All parameters were measured on arterial and central venous blood gases. Arterial and venous blood gas levels, blood lactate value, and oxyhemoglobin saturation were assayed using an automated analyzer (ABL800 FLEX, Radiometer, Bronshoj, Denmark). Central arteriovenous pCO 2 difference (mmHg) was calculated as: ΔPCO 2 ¼ PaCO 2 -PvCO 2 . The authors defined abnormal ΔPCO 2 gap 4 6 mmHg.
8,10,11
Endpoints
The primary endpoint was the percentage of patients with one or more complications.
The secondary endpoints were ScvO 2 , arterial and venous PO 2 , arterial and venous ph, arterial and venous PCO 2 , arterial and venous CO 2 , hemoglobin, arterial blood lactate, arterial blood lactate clearance between T0 and T1, and SOFA score.
Statistical Analysis
The distribution of the variables was assessed by a Kolmogorov-Smirnov test. Data are expressed as proportion (%), mean (SD), or median (25th-75th percentiles), as appropriate. The population was divided into 4 categories according to the time-course of ΔPCO 2 during the first 6 hours after surgery (between T0 and T1). Group 1 (Low-Low) was defined as the group in which the PCO 2 gradient remained low between T0 and T1; in group 2 (Low-High), the PCO 2 gradient increased; in group 3 (High-Low), the PCO 2 gradient decreased between T0 and T1; and finally, in group 4 (HighHigh), the PCO 2 gradient remained high. The non-parametric Wilcoxon rank sum test, Student's paired t-test, Student's t-test, Mann-Whitney test, Kruskal-Wallis test, and analysis of variance with Bonferroni post hoc correction were used to assess statistical significance, as appropriate. Categorical variables were compared by using Chi-square or Fisher's exact test. Associations among ΔPCO 2 , perfusion parameters (ScvO 2 , lactate), and blood gas parameters were tested by using Pearson's or Spearman's rank method. The limit of statistical significance was defined as p o 0.05. SPSS software (version 22, IBM, New York, NY) was used for statistical analysis.
Results
Baseline Patient Characteristics
During the study period, 557 patients were admitted to the ICU and 393 of them were included (Fig 1) ; 164 patients presenting exclusion criteria (n ¼ 78) or with missing data (n ¼ 87) were excluded. The median logistic EuroSCORE was 3.73% (1.41-4.28), mean age was 69 (12) years, and more than 50% of patients presented at least 2 cardiovascular risk factors (Table 1) . On admission to the ICU and on T1, 345 (88%) and 318 (81%) patients had a ΔPCO 2 greater than 6 mmHg, respectively.
Association Between ΔPCO 2 and Overall Complications
Of the 393 patients, 238 (61%) experienced one or more complications (Table 2) . CPB and aortic cross-clamping times were significantly longer in patients who developed complications. Arterial blood lactate levels were higher and ScvO 2 was lower in patients with postoperative complications. ΔPCO 2 was not significantly different between patients with and without complications (Table 3) .
Association Between Evolution of ΔPCO 2 and Postoperative Course
Baseline characteristics, postoperative complication rates, mortality rates, SOFA scores, and ICU length of stay were not significantly different among the 4 groups of patients (Table 4) . ScvO 2 and arterial blood lactate levels varied according to changes in ΔPCO 2 . Similarly, changes in ΔPCO 2 were related to changes in PaCO 2 and PvCO 2 during the study period (p o 0.05). In the overall cohort, ΔPCO 2 was correlated with hemoglobin (r ¼ 0.107, p ¼ 0.035), arterial blood lactate (r ¼
Discussion
The main findings of this study conducted on cardiac surgical patients were that ΔPCO 2 was not associated with postoperative complications and mortality, and was correlated weakly with perfusion parameters.
Although many studies have demonstrated lower morbidity with hemodynamic optimization, the authors' results did not support an association between ΔPCO 2 and postoperative course (morbidity, mortality, SOFA score, ICU length of stay). 17 These results contradicted those obtained with optimization of tissue parameters such as ScVO 2 and/or arterial lactate levels. 1 The absence of association between the ΔPCO 2 and the outcome of patients may be explained by physiopathology of the cardiac surgical population. The authors' results supported a role for changes in CO 2 production and factors determining the relationship between PvCO 2 and CO 2 content. As cardiac surgery may alter the distribution of systemic blood flow, metabolic status, body temperature, and alveolar ventilation, the relationship between PCO 2 and CO 2 content may change over time.
Most published studies have emphasized the key role of CO on ΔPCO 2 .
8-10,18-20 ΔPCO 2 is considered to be a marker of matching of CO to global metabolic demand, ie, a marker of matching of venous blood flow to eliminate total CO 2 produced by peripheral tissues. However, Ospina-Tascón et al, studying septic patients, showed that ΔPCO 2 was poorly correlated with CO, 19 while their results highlighted mechanisms other than low CO to explain high ΔPCO 2 in resuscitated septic patients. 19 Under steady-state conditions, ΔPCO 2 is determined by several factors: venoarterial CO 2 content difference, CO 2 dissociation curve, CO, and alveolar ventilation. 21 For a CO within the normal range, a high ΔPCO 2 could be related to high CO 2 production or changes in each factor determining the relationship between partial CO 2 pressure and CO 2 content.
Exposure of blood to CPB, gas microemboli, and systemic inflammatory response result in elevated oxidative stress with changes in the microcirculation and capillary permeability. 5, 6, 22 Cardiac surgery with CPB may increase CO 2 tissue production as a result of increased metabolic needs, redistribution of blood flow to peripheral tissues, and changes in hepatosplanchnic perfusion. 13 In 2000, Jakob et al demonstrated redistribution of systemic blood flow to peripheral tissues as a result of thermogenic and ischemia/reperfusioninduced vasodilator effects. 23 While VO 2 may increase in certain regions of the body, this flow redistribution can lead to a mismatch between DO 2 and VO 2 in other regions, especially in the hepatosplanchnic territory. 24 Takami et al demonstrated an increase of ΔPCO 2 in patients following cardiac surgery related to "invasiveness of surgery" attributed to CPB time and postoperative metabolic disorders (metabolic acidosis, arterial blood lactate level, creatine kinase peak level). 11 In this study, the authors demonstrated a weak correlation between ΔPCO 2 and various perfusion parameters (arterial blood lactate, ScvO 2 ). The impact of CPB on CO 2 production and acidbase balance may alter the relationship between partial CO 2 pressure and CO 2 content by changing metabolic conditions.
The role of the lungs and alveolar ventilation should be emphasized. CPB has been demonstrated to alter lung function and perfusion, and consequently gas exchange. 25 Hyperventilation has been shown to reduce PaCO 2 and increase ΔPCO 2 . 21 During the study period, the authors observed a lower PaCO 2 in patients with high ΔPCO 2 . Similarly, changes in ΔPCO 2 over time can be explained by the fact that all cardiac surgical patients are rewarmed and rapidly extubated. Extubation is associated with redistribution of systemic blood flow from peripheral tissues to respiratory muscles. 23 Hypothermia during surgery and rewarming in the ICU may have affected both CO 2 production and the relationship between CO 2 content and partial CO 2 pressure. 26 After myocardial revascularization, ΔPCO 2 was demonstrated to be a nonspecific parameter mostly influenced by VO 2 , body temperature, and PaCO 2 . 27 Several limitations may be considered. According to guidelines, the authors created a composite endpoint comprising several life-threatening complications. 16 The authors considered that it was not clinically relevant to distinguish each type of complications in order to evaluate ΔPCO 2 . This type of composite score has been used previously in studies evaluating the association between hemodynamic optimization and postoperative morbidity and mortality. 2, 3, 28 In the present study, incidence of complications seemed high, but they were close to those usually reported in the cardiac surgical area. 1, 2, 28, 29 Most of these complications were related to arrhythmia, which are demonstrated to occur in up to 40% of cardiac surgical patients. 2, 29 The authors' results were in line with those of previous studies that have demonstrated an association among ScvO 2 , arterial blood lactate values, and postoperative course. 8, 13 Another possible explanation for these differences could be the fact that the authors measured ΔPCO 2 on central and not mixed venous blood, which could lead to underestimation of CO 2 exchanges from splanchnic territories. Nevertheless, previous authors have demonstrated the good correlation between central ΔPCO 2 and mixed ΔPCO 2 to predict clinical outcome in sepsis, which is associated with altered perfusion of the splanchnic territory. 10 The relationship between ΔPCO 2 and CO therefore persists even when PvCO 2 is measured in central venous blood. 8 The authors conducted a single-center prospective observational study, in which a significant number of patients were excluded (mostly due to off-pump surgery). However, the authors' cohort remains the largest published cohort to evaluate ΔPCO 2 in this setting.
In conclusion, the authors did not demonstrate any association between ΔPCO 2 (and its time-course) and postoperative complications of cardiac surgery. However, ΔPCO 2 was associated weakly with tissue perfusion markers (ie, ScvO 2 , arterial lactate). The authors suggest that ΔPCO 2 should not be included in a predictive algorithm because it can be influenced by several factors that are modified considerably during the early hours following cardiac surgery.
